358 related articles for article (PubMed ID: 34683334)
41. Cross-Talk between Gut Microbiota and Heart via the Routes of Metabolite and Immunity.
Bu J; Wang Z
Gastroenterol Res Pract; 2018; 2018():6458094. PubMed ID: 29967639
[TBL] [Abstract][Full Text] [Related]
42. The Role of the Gut Microbiome and Trimethylamine Oxide in Atherosclerosis and Age-Related Disease.
El Hage R; Al-Arawe N; Hinterseher I
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768722
[TBL] [Abstract][Full Text] [Related]
43. Gut Microbiota-Derived Short-Chain Fatty Acids Facilitate Microbiota:Host Cross talk and Modulate Obesity and Hypertension.
Overby HB; Ferguson JF
Curr Hypertens Rep; 2021 Feb; 23(2):8. PubMed ID: 33537923
[TBL] [Abstract][Full Text] [Related]
44. Bridging the Gap between Gut Microbial Dysbiosis and Cardiovascular Diseases.
Lau K; Srivatsav V; Rizwan A; Nashed A; Liu R; Shen R; Akhtar M
Nutrients; 2017 Aug; 9(8):. PubMed ID: 28796176
[TBL] [Abstract][Full Text] [Related]
45. Role of Gut Microbiota on Cardio-Metabolic Parameters and Immunity in Coronary Artery Disease Patients with and without Type-2 Diabetes Mellitus.
Sanchez-Alcoholado L; Castellano-Castillo D; Jordán-Martínez L; Moreno-Indias I; Cardila-Cruz P; Elena D; Muñoz-Garcia AJ; Queipo-Ortuño MI; Jimenez-Navarro M
Front Microbiol; 2017; 8():1936. PubMed ID: 29051757
[TBL] [Abstract][Full Text] [Related]
46. The emerging role of gut microbiota in cardiovascular diseases.
Kumar D; Mukherjee SS; Chakraborty R; Roy RR; Pandey A; Patra S; Dey S
Indian Heart J; 2021; 73(3):264-272. PubMed ID: 34154741
[TBL] [Abstract][Full Text] [Related]
47. The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions.
Trøseid M; Andersen GØ; Broch K; Hov JR
EBioMedicine; 2020 Feb; 52():102649. PubMed ID: 32062353
[TBL] [Abstract][Full Text] [Related]
48. From obesity through gut microbiota to cardiovascular diseases: a dangerous journey.
Marzullo P; Di Renzo L; Pugliese G; De Siena M; Barrea L; Muscogiuri G; Colao A; Savastano S;
Int J Obes Suppl; 2020 Jul; 10(1):35-49. PubMed ID: 32714511
[TBL] [Abstract][Full Text] [Related]
49. The central and biodynamic role of gut microbiota in critically ill patients.
Wozniak H; Beckmann TS; Fröhlich L; Soccorsi T; Le Terrier C; de Watteville A; Schrenzel J; Heidegger CP
Crit Care; 2022 Aug; 26(1):250. PubMed ID: 35982499
[TBL] [Abstract][Full Text] [Related]
50. Gut Microbiota and Cardiovascular Disease: Evidence on the Metabolic and Inflammatory Background of a Complex Relationship.
Nesci A; Carnuccio C; Ruggieri V; D'Alessandro A; Di Giorgio A; Santoro L; Gasbarrini A; Santoliquido A; Ponziani FR
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240434
[TBL] [Abstract][Full Text] [Related]
51. Dietary metabolism, the gut microbiome, and heart failure.
Tang WHW; Li DY; Hazen SL
Nat Rev Cardiol; 2019 Mar; 16(3):137-154. PubMed ID: 30410105
[TBL] [Abstract][Full Text] [Related]
52. Role of Gut Microbiome in Cardiovascular Events: A Systematic Review.
Mansuri NM; Mann NK; Rizwan S; Mohamed AE; Elshafey AE; Khadka A; Mosuka EM; Thilakarathne KN; Mohammed L
Cureus; 2022 Dec; 14(12):e32465. PubMed ID: 36644080
[TBL] [Abstract][Full Text] [Related]
53. Gut Microbiota in Hypertension and Atherosclerosis: A Review.
Verhaar BJH; Prodan A; Nieuwdorp M; Muller M
Nutrients; 2020 Sep; 12(10):. PubMed ID: 33003455
[TBL] [Abstract][Full Text] [Related]
54. Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis?
Cao H; Zhu Y; Hu G; Zhang Q; Zheng L
Pharmacol Res; 2023 Jan; 187():106586. PubMed ID: 36460280
[TBL] [Abstract][Full Text] [Related]
55. Therapeutic potential of natural products against atherosclerosis: Targeting on gut microbiota.
Zhao X; Oduro PK; Tong W; Wang Y; Gao X; Wang Q
Pharmacol Res; 2021 Jan; 163():105362. PubMed ID: 33285231
[TBL] [Abstract][Full Text] [Related]
56. Fatty Acid Diets: Regulation of Gut Microbiota Composition and Obesity and Its Related Metabolic Dysbiosis.
Machate DJ; Figueiredo PS; Marcelino G; Guimarães RCA; Hiane PA; Bogo D; Pinheiro VAZ; Oliveira LCS; Pott A
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32521778
[TBL] [Abstract][Full Text] [Related]
57. Diet-gut microbiota interactions on cardiovascular disease.
Zhang X; Gérard P
Comput Struct Biotechnol J; 2022; 20():1528-1540. PubMed ID: 35422966
[TBL] [Abstract][Full Text] [Related]
58. Impact of gut microbiota: How it could play roles beyond the digestive system on development of cardiovascular and renal diseases.
Suganya K; Son T; Kim KW; Koo BS
Microb Pathog; 2021 Mar; 152():104583. PubMed ID: 33164814
[TBL] [Abstract][Full Text] [Related]
59. The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity.
Kasselman LJ; Vernice NA; DeLeon J; Reiss AB
Atherosclerosis; 2018 Apr; 271():203-213. PubMed ID: 29524863
[TBL] [Abstract][Full Text] [Related]
60. Exploring the Gut Microbiota and Cardiovascular Disease.
Murphy K; O'Donovan AN; Caplice NM; Ross RP; Stanton C
Metabolites; 2021 Jul; 11(8):. PubMed ID: 34436434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
